STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+：罗氏在中国生物技术公司的交易中超越单纯授权模式 罗氏正与中国的初创企业德凡德治疗公司合作，开发新药。 STAT+: Roche goes beyond licensing in deal with Chinese biotech statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app
